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CASE REPORT / OLGU SUNUMU 
A case of primary gastric choriocarcinoma and a review of the Turkish literature: 
An extremely rare carcinoma of the stomach
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çok nadir görülen bir kanseri
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ÖZET
Primer mide koryokarsinomu son derece nadir ve yüksek 
derecede malign bir tümördür. 60 yaşında bir erkek, mide 
ağrısı  ve  siyah  dışkılama  şikayetleri  ile  başka  bir  has-
taneye  başvurmuştu.  Üst  gastrointestinal  endoskopide 
mide korpusu ve antrumu dolduran ülserovejetan büyük 
bir tümör görülmüştü. Endoskopik biyopsi ile mide ade-
nokarsinomu  tanısı  konulmuştu.  Hasta  tedavi  için  has-
tanemize kabul edildi. Kanama ile komplike olmuş mide 
adenokarsinomu olarak değerlendirildi. Cerrahi gözlemde 
mide  korpusundan  kaynaklanan  kitlenin  transvers  ko-
lon ve pankreasa invaze olduğu görüldü. Çölyak aksta 
konglomere  lenfadenopatiler  vardı  ve  çölyak  damarları 
invaze etmiş idi. Palyasyon için subtotal gastrektomi ve 
genişletilmiş sağ hemikolektomi yapıldı. Patolojik incele-
mede sitotrofoblastlar ve sinsityotrofoblastlardan oluşan 
iki hücre paterninin tipik özellikleri görüldü. Tümör sadece 
koryokarsinomdan  ibaretti.  Koryokarsinom  kesin  tanısı 
için  immünohistokimyasal  testler  yapıldı.  Beta-HCG  ve 
EMA boyama pozitifti. Hasta ameliyattan 3 hafta sonra 
mide koryokarsinomu tanısı nedeniyle kontrole çağrıldı. 
Serum beta-HCG düzeyi458 mIU/mL idi (normal aralık, 
<0.5 mIU/mL). Testis veya mediastendeki primer bir kor-
yokarsinomu  ayırt  etmek  için  testis  ultrasonografisi  ve 
göğüs tomografisi yapıldı. Testlerde anormal bulgu sap-
tanmadı ve böylece primer mide koryokarsinomu tanısı 
kondu. Hasta kemoterapiyi reddetti. Üç ay sonra inguinal 
bölgede lenfadenopatileri ve çok sayıda akciğer metas-
tazları vardı. Cerrahiden 5 ay sonra solunum yetmezliği 
nedeniyle öldü.
Anahtar kelimeler: Koryokarsinom, mide, metastaz.
ABSRACT
Primary choriocarcinoma of the stomach is an extremely 
rare and highly malignant tumor. A 60 years old man vis-
ited another hospital for the chief complaint of the stom-
achache and black stools. A large ulcero-vegetative tumor 
occupying the gastric body and antrum was seen in the 
upper  gastrointestinal  endoscopy.  It  was  diagnosed  as 
gastric adenocarcinoma by endoscopic biopsy. The pa-
tient admitted to our hospital for treatment. The patient 
was assessed as a gastric adenocarcinoma complicated 
with hemorrhage. In the exploration, it was observed that 
the mass arising from gastric body was invaded the trans-
verse colon and pancreas. The lymphadenopaties in the 
celiac axis were conglomerated and had invaded the celi-
ac vessels. A subtotal gastrectomy and an extended right 
hemicolectomy were performed for palliation. In patholog-
ical findings, typical characteristics of two cell pattern con-
sisting of syncytiotrophoblasts and cytotrophoblasts were 
observed. The tumor consisted of only choriocarcinoma. 
For the definite diagnosis of choriocarcinoma, immuno-
histochemi-cal  tests  were  performed.  Beta-HCG  and 
EMA staining were positive. The patient was invited for 
control because of gastric choriocarcinoma three weeks 
later surgery. His serum beta-HCG level was 458 mIU/mL 
(normal range, <0.5 mIU/mL). For the differantiation from 
the primary choriocarcinoma in the testis or mediastinum, 
testicular ultrasonography and chest CT were performed. 
Abnormal findings were not detected in the tests, so it 
was diagnosed as primary gastric choriocarcinoma. The 
patient  refused  chemotherapy.  Three  months  later,  he 
had inguinal lymphadenopaties and multiple metastases 
in lung. He died 5 months after surgery because of respi-
ratory failure.
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INTRODUCTION
Choriocarcinoma  is  a  beta-human  chorionic  go-
nadotropin (beta-HCG) secreting, fast-growing and 
widely  metastatic  malignant  tumor  that  develops 
from trophoblastic or totipotential germ cells. Al-
most all choriocarcinomas form in the uterus after 
fertilization and arise from chorionic villi in associ-
ation with normal or abnormal gestation.1 However, 
it may also occur without associated gestation. Non-
gestational choriocarcinoma primarily occurs in the 
gonads as ovary or testis.2,3 Non-gestational forms 
may also occur as primarily in the extra-gonadal 
sites, such as mediastinum, liver, gall baldder, uri-
nary bladder, prostate and gastrointestinal system.4 
Primary  choriocarcinoma  of  the  stomach  is  ex-
tremely rare, and most such cases are not diagnosed 
correctly before operation.5 We report a case of pri-
mary gastric choriocarcinoma (PGC) diagnosed as 
gastric adenocarcinoma initially, and diagnosed as 
PGC by surgery.
CASE
A  60  years  old  man  visited  another  hospital  for 
the chief complaint of the stomachache and black 
stools. A  large  ulcerovegetative  tumor  occupying 
the gastric body and antrum accompanied by areas 
of hemorrhage and necrosis was seen in the upper 
gastrointestinal endoscopy. It was diagnosed as gas-
tric adenocarcinoma by endoscopic biopsy. The pa-
tient admitted to our hospital for treatment.
He had been suffering for 4 months from epi-
gastric pain and for a week from black stool. He had 
lost approximately 10 kg in body weight. He had 
not any significant medical history. The family his-
tory was negative for familial or hereditary disease. 
On examination, the patient was pale because of 
severe anemia, and had an ill-defined immobile epi-
gastric mass, approximately 8 cm by 15 cm in size. 
Supraclavicular, axillary and inguinal lymph nodes 
were not palpable. There was not any mass in the 
rectal digital examination, but there was mealena. 
Initial laboratory study results were normal, except 
for hemoglobin, at 8.6 g/dl, and a hematocrit of 25.9 
per cent. Computed tomography (CT) of the abdo-
men demonstrated a large necrotic tumor filled the 
2 to 3 of stomach, and multiple lymphadenopaties 
with necrotic areas in the celiac axis (Figure 1). As 
to tumor markers, serum carcinoembryonic antigen 
(CEA), alpha-fetoprotein (AFP), and carbohydrate 
antigen (CA) 19-9 levels were within normal limits.
Figure 1. Computed tomography cross-section of a 
large necrotic tumor filled gastric body.
Figure 2. The microscopic appearance of the two 
cell pattern consisting of syncytiotrophoblasts and 
cytotrophoblasts  and  the  wide  necrotic  areas  in 
choriocarcinoma (hematoxylen-eosin staining, x200 
magnification).
Figure 3. The microscopic appearance of the syn-
cytial  cells  showed  positive  immunoreactivity  for 
beta-human chorionic gonadotropin (x200 magnifi-
cation)C. Kırkıl, et al. Primary gastric choriocarcinoma 107
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The patient was assessed as a gastric adenocar-
cinoma complicated with hemorrhage. The gastric 
resection and lymph node dissection were decided 
for surgical treatment. In the exploration by midline 
incision, it was observed that the mass arising from 
gastric body was invaded the transverse colon and 
pancreas. And the lymphadenopaties in the celiac 
axis were conglomerated, and had invaded the ce-
liac vessels. A subtotal gastrectomy and an extended 
right hemicolectomy were performed for palliation. 
Polya  gastrojejunostomy  and  ileotransversostomy 
were preferred for reconstructions. There was no 
operation-related mortality or morbidity.
In  pathological  findings,  tumor  size  was 
12x10x4  cm  and  typical  characteristics  of  two-
cell pattern consisting of syncytiotrophoblasts and 
cytotrophoblasts were observed all of the sections 
(Figure 2). The tumor consisted of only choriocar-
cinoma, there was not adenocarcinoma component. 
For the definite diagnosis of choriocarcinoma, im-
munohistochemical test was performed. Beta-HCG 
and EMA staining were positive, AFP staining was 
negative (Figure 3). The patient was invited for con-
trol because of gastric choriocarcinoma three weeks 
later surgery. His serum beta-HCG level was 458 
mIU/mL (normal range, <0.5 mIU/mL). For the dif-
ferentiation from the primary choriocarcinoma in 
the testis or mediastinum, testicular ultrasonography 
and chest CT were performed. Abnormal findings 
were not detected in the tests, so it was diagnosed as 
PGC. The patient was advised a chemotherapy regi-
men but he refused chemotherapy. Three months 
later, he had inguinal lymphadenopaties and mul-
tiple metastases in lung. He died 5 months after sur-
gery because of respiratory failure.
Table 1. Demographics and characteristics of the patients reported in Turkey
Author(s) Coskun et al. Bayhan et al. Gursoy et al. Deniz et al. Present
Year 1998 2000 2000 2006 2010
Age 37 26 38 44 60
Sex Female Female Female Male Male
Endoscopic
 biopsy
Choriocarcinoma Not taken Choriocarcinoma Adenocarcinoma Adenocarcinoma
Location Antrum Great curvature Antrum Antrum Corpus and antrum
Depth 
(involved organ)
NA UM NA T2 T4 (colon and pancreas)
Surgery - Tumor resection - Total gastrectomy +
Omentectomy
Subtotal gastrectomy +
Extended right
 hemicolectomy
Indication NA Bleeding NA UM Bleeding
Residual tumor
 classification NA UM NA R2 R2
Size UM 3x2x1 cm UM 3x2 cm 12x10x4 cm
Pure or mixed
Pure (having only
 Endoscopic
 biopsies)
UM UM 2/3 chorio +
 1/3 adeno
Pure 
Lymph node + UM UM + +
Metastases Liver Lung (postop) Liver Liver Lung (postop)
Chemotherapy Unknown regimen
Methotrexate +
 Dactinomycin +
Cyclophosphamide
Methotrexate + 
Etoposid
Unknown regimen -
Prognosis UM
18 months,
 disease free 12 days, death 4 months, death 5 months, death
Cause of death UM NA Bleeding, DIC,
Hepatic insufficiency
UM Respiratory failure
UM: unmentioned; NA: not allowedC. Kırkıl, et al. Primary gastric choriocarcinoma 108
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PRIMARY GASTRIC CHORIOCARCINOMA 
CASES REPORTED FROM TURKEY
To date, four cases with PGCs apart from the pres-
ent  case  had  been  reported  in Turkey. The  table 
summarizes the characteristics and demographics of 
the patients. Three articles had published in English, 
one in Turkish.6-9 The data about these patients was 
not comparable and there were a lot of lost data, as 
survival, the indications and the techniques of sur-
gery. Three patients had liver metastases at the time 
of initial diagnosis. Two of them underwent liver bi-
opsy as well as endoscopic biopsy, and they truly di-
agnosed. Having only endoscopic biopsies, the au-
thors thought that they were pure choriocarcinomas. 
The remaining patient underwent only endoscopic 
biopsy and misdiagnosed as adenocarcinoma. Three 
patients underwent surgery. Two of them died with-
in 5 months; only one patient lived disease free for 
18 months after surgery. Four patients had chemo-
therapy but one of them died because of bleeding 
into the mass followed by disseminated intravascu-
lar coagulation and hepatic insufficiency at the 12th 
day of chemotherapy.
DISCUSSION
Primary  gastric  choriocarcinoma  is  a  rare  tumor 
that is reported to account for approximately 0.08% 
of all gastric cancers.10 The number of PGC cases 
reported  in  international  medical  literature  (as  a 
PubMed  based  literature  screening)  has  not  yet 
reached to one hundred and fifty. The clinicopath-
ology and prognostic factors of PGC is not clear, 
because most studies reported to date are the case 
reports or small series. However, Kobayashi et al 
reported that male/female ratio was 2.3:1, median 
age was 63 years, and most frequently location was 
the lower third of the stomach in a pooled analysis 
of 53 patients with PGC. The mean tumor size was 
7 cm and nearly all the tumors were accompanied 
by macroscopic hemorrhage or necrosis. Seventy 
per cent of patients had PGCs that exhibited an ad-
enocarcinoma component.10 The presented patient 
who had 60 years old man was consistent with the 
literature and had a necrotic large tumor.
Several theories regarding the pathogenesis of gas-
tric choriocarcinoma have been presumed. Accord-
ing to the most accepted view known as retrodiffer-
entiation theory, the trophoblastic elements present 
in primary gastric choriocarcinoma are differentiat-
ed from malignant adenomatous tissue. By 30% of 
the reported cases were pure choriocarcinomas and 
some authors proposed that this might be the result 
of complete replacement of gastric adenocarcinoma 
by choriocarcinoma or metaplasia of gastric adeno-
carcinoma  to  choricarcinoma. The  most  cases  of 
PGCs are not diagnosed correctly before operation 
because of the coexistence of adenocarcinoma and 
choriocarcinoma. The rates of correctly diagnosed 
PGCs by endoscopic biopsies were between 8% and 
15%. Similarly, our patient had misdiagnosed as ad-
enocarcinoma after endoscopic biopsy. In fact, there 
was no adenocarcinoma component in this case. It 
recommended that clinicians should take more bi-
opsy specimens when encountering large and hem-
orrhagic tumors, in order to correctly diagnose the 
gastric choriocarcinoma.5 Kobayashi et al reported 
that most patients with Primary gastric choriocar-
cinoma had metastatic lesions at the time of opera-
tion. The rates of lymph node, liver, peritoneal, and 
lung metastases were 87%, 45%, 23%, and 8%, re-
spectively. The percentage of patients with a cho-
riocarcinoma  component  in  the  liver  was  96%.10 
It  means  that  the  choriocarcinoma  component  of 
the tumor was more capable to metastasis into the 
liver than adenocarcinoma component. So, it may 
explain why the accurate diagnosis more possible 
in patients with liver metastases underwent biopsy. 
In our case, the patient hadn’t got any metastases 
at the presentation. But, the lung metastases were 
occured 3 months later. The most of patients with 
PGCs were died at 6 months after surgery.10 Our pa-
tient also died 5 months later than surgery because 
of respiratory failure. However, Noguchi et al re-
ported a patient had live for 4 years and 6 months 
after gastrectomy followed by chemotherapy.5 The 
most frequent cause of death in patients with PGCs 
was  hepatic  failure  because  of  tumor  metastasis, 
and the cancerous hemorrhage was the next. The 
synchronous liver metastasis, residual tumor after 
surgery,  and  the  absence  of  chemotherapy  were 
significant prognostic parameters of a short over-
all survival.10 For the treatment of gastric chorio-
carcinoma,  chemotherapy  engaging  methotrexate, 
actinomycin D, etoposide, folinic acid, vincristin, 
cyclophosphoamide, etc. is the main therapy, and as 
supplement, surgery or radiation therapy is admin-
istered. Kobayashi et al discussed that the presence 
of synchronous liver metastasis at the time of op-C. Kırkıl, et al. Primary gastric choriocarcinoma 109
Dicle Tıp Derg / Dicle Med J    www.diclemedj.org   Cilt / Vol 39, No 1, 105-109
eration might represent an advanced metastatic state 
and might be associated with a poor clinical course 
in PGC patients.10 They suggested that a palliative 
gastrectomy should never be performed in such pa-
tients, as it is likely that the patients would die soon 
after such a procedure. On the contrary, Yoon et al 
advocated that such a treatment should be consid-
ered for the treatment of choriocarcinomas causing 
gastrointestinal bleeding.11
In conclusion, preoperative diagnosis of PGC is dif-
ficult. Physicians must be careful and should take 
more biopsy specimens when they encounters with 
a old patient has large necrotic and hemorrhagic tu-
mor on the stomach.
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